News

WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the treatment of exudative retinal diseases.Rahimy said that even with the success of anti-VEGF therapies, many patients with age-related macular degeneration and diabetic macular edema are incomplete or suboptimal responders.{{VIDEO}}“That begs … [Read more...] about IL-6 inhibition promising as pathway for retinal disease therapy

LAS VEGAS — Effective mentorship can accelerate careers, but toxic mentoring behaviors can just as easily derail academic progress if left unchecked, Frank I. Scott, MD, MSCE, warned attendees at Crohn’s & Colitis Congress.“We know that mentorship can positively influence career trajectories,” Scott, codirector of Crohn’s & Colitis Foundation’s IBD Qorus and associate … [Read more...] about Set boundaries, expectations to prevent ‘mentorship malpractice’

To investigate the association between maternal health conditions and the risk of retinopathy of prematurity (ROP) in preterm infants using nationwide population-based data. … [Read more...] about Maternal risk factors for retinopathy of prematurity in Korea : A nationwide population-based study

To describe the impact of social determinants of health (SDOH) on visual acuity (VA) at presentation among patients with retinal vein occlusion (RVO) … [Read more...] about Influence of Social Determinants of Health on Presenting Visual Acuity in Retinal Vein Occlusions

Voretigene neparvovec (VN), developed for the treatment of inherited retinal dystrophy associated with confirmed biallelic RPE65 mutations (RPE65-IRD), is the first approved retinal gene therapy. Recently, reports have emerged of chorioretinal atrophy (CRA) developing in a subset of patients treated with VN. Although researchers have started to investigate the etiology, … [Read more...] about Expert consensus on characteristics, etiology and management of chorioretinal atrophy in patients treated with voretigene neparvovec